SSRI or SNRI antidepressant use may increase risk of type 2 diabetes in youthsStudy shows risk intensifies with increasing duration of use, cumulative dose and average daily dose Pharmacy U Vancouver: Well-rounded agenda aims to help pharmacies build a sustainable future Why should Naloxone be free if other life-saving medications aren't? By handing out the kits without requirements for counseling, we're enabling damaging behaviour Liberals accused of diabetes tax grab with apparent benefit clawback Type 2 diabetes: tips for pharmacists Top 10 points to consider when caring for patients with type 2 diabetes Alberta pilot study results Pharmasave and UBC launch therapeutic nutrition program for diabetes 13 stores across B.C. will be taking part in the pharmacist-led clinical trial The future is now Drug benefit plan managers and sponsors often overlook pharmacists At the 2017 drug benefits summit, Mark Rolnick of Shoppers Drug Mart suggested opportunities are being missed Tresiba (insulin degludec): third basal insulin analogue in Canada Glucose-lowering effect of ultralong-acting basal insulin lasts for more than 42 hours First Previous 93 94 95 96 97 Next Last
